pgRNA-modified Citations (5)

Originally described in: Editing DNA Methylation in the Mammalian Genome.
Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S, Shu J, Dadon D, Young RA, Jaenisch R Cell. 2016 Sep 22;167(1):233-247.e17. doi: 10.1016/j.cell.2016.08.056. PubMed Journal

---

Articles Citing pgRNA-modified

Articles
p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino. Marney CB, Anderson ES, Adnan M, Peng KL, Hu Y, Weinhold N, Schmitt AM. Cell Rep. 2021 Jun 29;35(13):109329. doi: 10.1016/j.celrep.2021.109329. PubMed
Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer. Wang C, Leavenworth J, Zhang C, Liu Z, Yuan KY, Wang Y, Zhang G, Wang S, Cui X, Zhang Y, Bae S, Zhou J, Wang L, Liu R. Oncogene. 2022 May;41(19):2778-2785. doi: 10.1038/s41388-022-02272-3. Epub 2022 Mar 31. PubMed
CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy. Xu C, Jiang S, Ma X, Jiang Z, Pan Y, Li X, Zhang L, Zhou H, Chen S, Xing X, Chen L, Fu W, Wang Q, Chen W, Li D. Arch Toxicol. 2023 Feb;97(2):441-456. doi: 10.1007/s00204-022-03404-0. Epub 2022 Nov 6. PubMed
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer. Apolonio JD, Dias JS, Fernandes MT, Komosa M, Lipman T, Zhang CH, Leao R, Lee D, Nunes NM, Maia AT, Morera JL, Vicioso L, Tabori U, Castelo-Branco P. Clin Epigenetics. 2022 Dec 18;14(1):178. doi: 10.1186/s13148-022-01396-3. PubMed
CRISPR/dCas9-Tet1-Mediated DNA Methylation Editing. Qian J, Liu SX. Bio Protoc. 2024 Apr 20;14(8):e4976. doi: 10.21769/BioProtoc.4976. eCollection 2024 Apr 20. PubMed

If you have published an article using this material, please email us at to have your article added to this page.